English
This article is from Journal of Pharmacy & Bioallied Sciences , volume 6 . Abstract Background:: The emergence of multidrug-resistant strains of Staphylococcus aureus, there is an urgent need for the development of new antimicrobials which are narrow and pathogen specific. Aim:: In this context, the present study is aimed to have a control on the staphylococcal infections by targeting the unique and essential enzyme; porphobilinogen synthase (PBGS) catalyzes the condensation of two molecules of δ-aminolevulinic acid, an essential step in the tetrapyrrole biosynthesis. Hence developing therapeutics targeting PBGS will be the promising choice to control and manage the staphylococcal infections. 4,5-dioxovalerate (DV) is known to inhibit PBGS. Materials and Methods:: In view of this, in this study, novel dioxovalerate derivatives (DVDs) molecules were designed so as to inhibit PBGS, a potential target of S. aureus and their inhibitory activity was predicted using molecular docking studies by molecular operating environment. The 3D model of PBGS was constructed using Chlorobium vibrioform (Protein Data Bank 1W1Z) as a template by homology modeling method. Results:: The built structure
Sign in with your free account to read, download EPUBs or listen.
Ebook · In silico designing and molecular docking of a potent analog against Staphylococcus aureus porphobilinogen synthase. · Kumar, Pasupuleti Santhosh, Kumar, Yellapu Nanda, Prasad, Uppu Venkateswara, Yeswanth, Sthanikam, Swarupa, Vimjam, Sowjenya, Gopal, Venkatesh, Katari, Srikanth, Lokanathan · Internet Archive